TotalMarketCap

Seres Therapeutics

MCRBNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$21.308 M

$2.09 +0.00%

Close of 6 Nov 2026

As of 6 Nov 2026, Seres Therapeutics (MCRB) has a market capitalization of $21.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$789.0K

#3478 by revenue

Earnings

$5.70M

#2154 by earnings

Shares outstanding

10,195,031

Latest filing cover page

P/E ratio

3.7

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #379Filana TherapeuticsFLNA$21.7M
  2. #380IGC PharmaIGC$21.6M
  3. #381Seres TherapeuticsMCRB$21.3M
  4. #382ImmutepIMMP$20.6M
  5. #383Atossa TherapeuticsATOS$20.1M

What if Seres Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,769,670

Per share 1,325,201× higher

Bitcoin $1.53T

$149,862.03

Per share 71,704× higher

Apple $5.02T

$491,983.06

Per share 235,399× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Seres Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.